glp-1 obesity drug news today 2025 2024 was a record year for trials and is already poised to take over Dozens of new obesity drugs
Description
Learn about the Zepbound blindness lawsuit, including NAION and other eye side effects, and read about a study linking GLP-1 RAs to severe vision problems.
This innovative oral GLP-1 is a small molecule medication that, unlike the Wegovy pill, doesnt require that you take it on an empty stomach.
GLP-1 is a peptide hormone secreted by L cells in the ileum and colon
The product also includes BCAAs, which not only support muscle endurance but also contribute to a healthier gut environment by supporting digestive health
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo
COA included
